Ballicules.com

Acetylcysteine

ACETADOTE

What it isGlutathione-repleting antidote and disulfide-breaking mucolytic; acetaminophen toxicity and thick airway secretions.

Why this oneIt works best early after overdose but can still benefit established hepatic injury, so delayed presentation is not a reason to withhold it.

What limits itIV use can trigger anaphylactoid reactions; inhalation can provoke bronchospasm. Nausea and sulfur odor impair completion.

FDA label

FDA dosingPopulationStartTargetMax
Mucolytic — nebulization via face mask, mouthpiece, or tracheostomyMost patients3-5 mL of 20% (or 6-10 mL of 10%) TID-QID3-5 mL of 20% (or 6-10 mL of 10%) TID-QID1-10 mL of 20% (or 2-20 mL of 10%) q2-6h
Mucolytic — direct instillation (incl. tracheostomy care)All1-2 mL of 10-20% q1-4h (PRN as often as hourly)1-2 mL q1-4hq1h
Diagnostic bronchograms (pre-procedure)All1-2 mL of 20% (or 2-4 mL of 10%) x2-3 doses by nebulization or intratracheal instillation before procedureSame2-3 administrations

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy No adequate human studies; animal reproduction studies (up to 2.6x human dose) showed no harm — use only if clearly needed

Lactation Undefined

NO BOXED WARNINGS

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Acetylcysteine ballicule

Acetylcysteine ballicule: receptor binding, kinetics and half-life diagram

Open Acetylcysteine in the interactive console ↗